Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème
0.3.0 - trial-use
Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2024-02-26 |
{
"resourceType" : "CodeSystem",
"id" : "eclaire-study-phase-source-code-system",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">jarde-early<a name=\"eclaire-study-phase-source-code-system-jarde-early\"> </a></td><td>Jardé phase précoce</td></tr><tr><td style=\"white-space:nowrap\">phase-I-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-first-admin\"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-bioequivalence\"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-other<a name=\"eclaire-study-phase-source-code-system-phase-I-other\"> </a></td><td>Human Pharmacology (Phase I) - Other</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-admin\"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-bioequivalence\"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-other<a name=\"eclaire-study-phase-source-code-system-phase-I-II-other\"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style=\"white-space:nowrap\">phase-II<a name=\"eclaire-study-phase-source-code-system-phase-II\"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style=\"white-space:nowrap\">phase-II-III<a name=\"eclaire-study-phase-source-code-system-phase-II-III\"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style=\"white-space:nowrap\">phase-III<a name=\"eclaire-study-phase-source-code-system-phase-III\"> </a></td><td>Therapeutic confirmatory (Phase III)</td></tr><tr><td style=\"white-space:nowrap\">phase-IV<a name=\"eclaire-study-phase-source-code-system-phase-IV\"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style=\"white-space:nowrap\">phase-III-IV<a name=\"eclaire-study-phase-source-code-system-phase-III-IV\"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>"
},
"url" : "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system",
"version" : "0.3.0",
"name" : "EclaireStudyPhaseSourceCS",
"title" : "Définition des phase de l'essai utilisés dans la base de données ECLAIRE",
"status" : "draft",
"date" : "2024-02-26T09:56:13+00:00",
"publisher" : "ANS",
"contact" : [
{
"name" : "ANS",
"telecom" : [
{
"system" : "url",
"value" : "https://esante.gouv.fr"
}
]
}
],
"description" : "Définition des phases de l'essai utilisées dans la base de données ECLAIRE",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "FR",
"display" : "FRANCE"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 12,
"concept" : [
{
"code" : "jarde-early",
"display" : "Jardé phase précoce"
},
{
"code" : "phase-I-first-admin",
"display" : "Human Pharmacology (Phase I) - First administration to humans"
},
{
"code" : "phase-I-bioequivalence",
"display" : "Human Pharmacology (Phase I) - Bioequivalence Study"
},
{
"code" : "phase-I-other",
"display" : "Human Pharmacology (Phase I) - Other"
},
{
"code" : "phase-I-II-first-admin",
"display" : "Phase I and Phase II (Integrated) - First administration to humans"
},
{
"code" : "phase-I-II-first-bioequivalence",
"display" : "Phase I and Phase II (Integrated) - Bioequivalence Study"
},
{
"code" : "phase-I-II-other",
"display" : "Phase I and Phase II (Integrated) - Other"
},
{
"code" : "phase-II",
"display" : "Therapeutic exploratory (Phase II)"
},
{
"code" : "phase-II-III",
"display" : "Phase II and Phase III (Integrated)"
},
{
"code" : "phase-III",
"display" : "Therapeutic confirmatory (Phase III)"
},
{
"code" : "phase-IV",
"display" : "Therapeutic use (Phase IV)"
},
{
"code" : "phase-III-IV",
"display" : "Phase III and phase IV (Integrated)"
}
]
}